|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBSCO_ocn984523853 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
170317s2017 xx ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d N$T
|d OCLCF
|d OCLCQ
|d VLB
|d AGLDB
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d OCLCQ
|d G3B
|d S8I
|d S8J
|d STF
|d D6H
|d MQY
|d OCLCO
|d OCLCQ
|d PSYSI
|d OCLCQ
|
| 019 |
|
|
|a 975096767
|a 975397921
|a 975871689
|a 976106390
|a 976262358
|a 978384756
|a 984335477
|a 985212678
|a 1006803885
|
| 020 |
|
|
|a 1681083434
|q (electronic bk.)
|
| 020 |
|
|
|a 9781681083438
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)984523853
|z (OCoLC)975096767
|z (OCoLC)975397921
|z (OCoLC)975871689
|z (OCoLC)976106390
|z (OCoLC)976262358
|z (OCoLC)978384756
|z (OCoLC)984335477
|z (OCoLC)985212678
|z (OCoLC)1006803885
|
| 050 |
|
4 |
|a RC564
|b .S83 2017
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.86
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a SUBSTANCE AND NON SUBSTANCE RELATED ADDICTION DISORDERS :
|b diagnosis and treatment (1).
|
| 260 |
|
|
|a [Place of publication not identified] :
|b BENTHAM Science PUBLISHER,
|c 2017.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
8 |
|
|a FOREWORD ; PREFACE ; List of Contributors ; Section I: General Topics ; Neurobiology and Psycho-Social Basis for Addiction and Related Disorders ; KEY LEARNING POINTS; NEUROBIOLOGY OF ADDICTION AND REWARD PATHWAYS; PSYCHOSOCIAL FACTORS; ADVERSE CHILDHOOD EXPERIENCES (ACE); CONFLICT OF INTEREST; ACKNOWLEDGEMENTS ; REFERENCES; Urine Drug Screening (UDS) in the Management of Substance Use Disorders ; KEY LEARNING POINTS; CLINICAL VIGNETTE; DIAGNOSTIC CONSIDERATION; REASONS FOR OBTAINING AN UDS; URINE DRUG SCREENS; Types of Urine Drug Tests; Urine Drug Test as a Follow-up Tool.
|
| 505 |
8 |
|
|a Urine Sample CollectionChain of Custody; Medication Interfering with UDS; SPECIAL CONSIDERATIONS; Opiate/Opioid Metabolism; Benzodiazepines; Untested Substances; Altered Pharmacokinetic and Pharmacodynamic Parameters; SUMMARY; PATIENT INFORMATION SHEET -- URINE DRUG SCREENS; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS ; REFERENCES; Genetics of Addiction ; KEY LEARNING POINTS; GENETICS OF ADDICTION; SUMMARY; PATIENT EDUCATION SHEET; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Dual Diagnosis ; KEY LEARNING POINTS; CLINICAL VIGNETTE; BACKGROUND; DIAGNOSTIC CONSIDERATIONS.
|
| 505 |
8 |
|
|a TREATMENT CONSIDERATIONSTREATMENT OUTCOMES; SUMMARY; DUAL DIAGNOSIS -- PATIENT INFORMATION SHEET; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS ; REFERENCES; Pharmacologic Treatment for Psychiatric Disorders Associated with Substance Use Disorders: An Overview ; KEY LEARNING POINTS; INTRODUCTION; Benzodiazepines (Table 1); Antidepressants; Serotonin Syndrome; Syndrome Presentation; Treatment; SSRI Withdrawal Phenomenon; Atypical/Typical Antipsychotics; Dosing; Monitoring; Additional Monitoring Recommended; Other Side Effects; Extrapyramidal Side Effects (EPSE); Treatment of Early -- EPSE.
|
| 505 |
8 |
|
|a Dystonias and PseudoparkinsonismAkathisia; Treatment of Tardive Dyskinesia; Neuroleptic Malignancy Syndrome (NMS); Mood Stabilizers; Anticonvulsants; Management of Insomnia; SUMMARY; PATIENT INFORMATION -- MEDICATIONS FOR SUBSTANCE USE DISORDERS; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS ; REFERENCES; Motivational Interviewing ; KEY LEARNING POINTS; BACKGROUND; PROCESS; MOTIVATION ENHANCEMENT; THE STAGES OF CHANGE; SUMMARY; MOTIVATIONAL INTERVIEW-PATIENT EDUCATION SHEET; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Section II: Substance-Related Addiction Disorders (Alphabetical).
|
| 505 |
8 |
|
|a Alcohol Use Disorders KEY POINTS; CLINICAL VIGNETTE; INTRODUCTION; Epidemiology; Etiology; Diagnosis; Non-Pharmacologic Interventions; Pathophysiology of Alcohol Use Disorders (AUD); PHARMACOTHERAPY FOR ALCOHOL USE DISORDERS (AUD); Management of Outpatient Alcohol Withdrawal; FDA Approved Medications for Alcohol Use Disorder [26]; Disulfiram (Antabuse®) [19, 21, 27]; Naltrexone (Revia® (PO), Vivitrol® (IM)); Acamprosate (Campral®) [21, 28, 30]; Combination Therapy; Non-FDA Approved Pharmacotherapies for AD; SUMMARY; CLINICAL VIGNETTE RESOLUTION; PROVIDER RESOURCES.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Substance abuse
|x Diagnosis.
|
| 650 |
|
0 |
|a Substance abuse
|x Treatment.
|
| 650 |
|
0 |
|a Compulsive behavior.
|
| 650 |
|
2 |
|a Compulsive Behavior
|
| 650 |
|
2 |
|a Behavior, Addictive
|
| 650 |
|
6 |
|a Polytoxicomanie
|x Traitement.
|
| 650 |
|
6 |
|a Comportement compulsif.
|
| 650 |
|
7 |
|a addiction.
|2 aat
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Compulsive behavior.
|2 fast
|0 (OCoLC)fst00871935
|
| 650 |
|
7 |
|a Substance abuse
|x Diagnosis.
|2 fast
|0 (OCoLC)fst01136772
|
| 650 |
|
7 |
|a Substance abuse
|x Treatment.
|2 fast
|0 (OCoLC)fst01136830
|
| 700 |
1 |
|
|a Bhatia, Subhash C.,
|e editor.
|
| 700 |
1 |
|
|a Petty, Frederick,
|e editor.
|
| 700 |
1 |
|
|a Gabel, Teri,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Bhatia, Subhash C.
|t Substance and Non Substance Related Addiction Disorders: Diagnosis and Treatment.
|d Sharjah : Bentham Science Publishers, ©2017
|z 9781681083445
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1483672
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1483672
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13586364
|
| 994 |
|
|
|a 92
|b IZTAP
|
